Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Infectious Disease
•
Travel and Tropical Medicine
•
Neurocysticercosis
Are there clinical circumstances in which there is a role for steroids in treatment of calcified neurocysticercosis associated with perilesional edema and seizures?
Related Questions
What is your approach to monitoring patients with the indeterminate form of Chagas disease?
Do you routinely refer all patients with cutaneous leishmaniasis with a species associated with mucocutaneous leishmaniasis to ENT for comprehensive nasal/oropharyngeal evaluation, or do you refer only if mucocutaneous involvement is suspected based on careful clinical assessment and/or bedside exam?
What is your approach to the duration of antiparasitic therapy for treatment of subarachnoid neurocysticercosis?
Do you treat subarachnoid neurocysticercosis with albendazole alone, or with addition of praziquantel?
Do you routinely transition from inpatient vancomycin to outpatient daptomycin to decrease the risk of nephrotoxicity and reduce the burden of lab monitoring in a patient with MRSA infection being discharged on home IV antibiotics?
What is your approach to deciding when to stop therapy for cutaneous Mycobacterium chelonae infections?
Are there instances when you do not recommend tunneled dialysis catheter exchange in patients on hemodialysis who are found to have bacteremia?
Do you treat Stenotrophomonas maltophilia bacteremia with combination therapy and if so, what is your preferred combination of antibacterials?
For how long do you treat an early spinal hardware infection secondary to MSSA after operative washout and retention of hardware?
How long would you treat a patient with recent history of TAVR presenting with E faecalis bacteremia with unclear source with TEE showing thickened valves but no obvious vegetation?
